Once matured and loaded with antigen, these DCs are reinfused intradermally, subcutaneously, or intravenously, where they migrate to lymph nodes and present tumor‐derived peptides on MHC molecules to naïve CD8+ and CD4+ T cells. Here, HLA-C is linked to neoplasm.